Business
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
About this update from Genscript Biotech Corporation
[{"type":"text","content":"Group Performance","length":17,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue: US$959.5 million, +61.4% year-on-year","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross profit: US$553.2 million, +103.3% year-on-year","length":52,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted net profit: US$230.3 million, +285.0% year-on-year","length":59,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":157,"olType":false},{"type":"text","content":"Business Units' Performance","length":31,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"GenScript Life Science Group (LSG): US$522.1 million, +14.8% year-on-year","length":73,"tagName":"p"}]},{"val":[{"type":"text","content":"ProBio: US$388.7 million, +309.1% year-on-year","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Bestzyme: US$58.0 million, +7.9% year-on-year","length":45,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":164,"olType":false},{"type":"text","content":"PISCATAWAY, N.J., March 16, 2026 /PRNewswire/ --","length":48,"tagName":"p"},{"type":"image","alt":"GenScript Biotech Corporation continues to scale platform synergies, global reach, and automation-enabled operations, with revenue reaching US$959.5 million (+61.4% YoY); adjusted net profit rising up to US$230.3 million.","displaySize":"","headline":null,"caption":"GenScript Biotech Corporation continues to scale platform synergies, global reach, and automation-enabled operations, with revenue reaching US$959.5 million (+61.4% YoY); adjusted net profit rising up to US$230.3 million.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/edf070fb5f402cb0cc5615f6e4454a62"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rzCsSrAocGmgSodlWGqx2Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/edf070fb5f402cb0cc5615f6e4454a62","width":400,"height":225}}},{"type":"text","content":"GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology innovation, today announced financial results for full year 2025.","length":262,"tagName":"p"},{"type":"text...